News articles about Metlife (NYSE:MET) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Metlife earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 48.0845504133695 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the media stories that may have effected Accern Sentiment’s scoring:

Shares of Metlife (NYSE MET) traded down $4.75 during trading on Tuesday, hitting $49.65. The stock had a trading volume of 11,616,267 shares, compared to its average volume of 4,837,353. The firm has a market capitalization of $57,250.00, a price-to-earnings ratio of 107.82, a PEG ratio of 1.22 and a beta of 1.49. Metlife has a 12 month low of $44.26 and a 12 month high of $55.91. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31.

Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.19. The firm had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. Metlife’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.28 earnings per share. equities analysts anticipate that Metlife will post 4.42 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Monday, February 5th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.22%. The ex-dividend date is Friday, February 2nd. Metlife’s payout ratio is 347.83%.

A number of research analysts have recently weighed in on MET shares. TheStreet upgraded Metlife from a “c+” rating to a “b” rating in a research report on Wednesday, October 4th. Zacks Investment Research raised Metlife from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a research note on Thursday, November 9th. ValuEngine lowered Metlife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Argus lifted their price objective on Metlife from $55.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, November 6th. Finally, Wells Fargo & Co reaffirmed a “buy” rating on shares of Metlife in a research note on Wednesday, October 18th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Metlife presently has a consensus rating of “Hold” and a consensus target price of $57.77.

In related news, insider Christopher G. Townsend sold 55,712 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the transaction, the insider now owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christopher G. Townsend sold 82,731 shares of the business’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now directly owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

WARNING: This piece was posted by Marea Informative and is the property of of Marea Informative. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at

About Metlife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with's FREE daily email newsletter.